首页> 外文期刊>Journal of Clinical Pharmacy and Therapeutics >Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea.
【24h】

Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea.

机译:茶碱在非常早熟的日本呼吸暂停婴儿中的群体药代动力学。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To estimate the population pharmacokinetics of theophylline in very premature infants using the non-linear mixed effects modelling. METHOD: A total of 167 serum concentration measurements obtained from routine theophylline monitoring of 107 very premature Japanese infants were collected. RESULTS: The final pharmacokinetic parameters were CL (mL/h) = [6.98 . body weight (BW) (kg)(2.17) + 0.244 . post-conceptional age (weeks)] . 1.24(oxygen support), Vd (L) = 0.492 . BW (kg) and F = 0.660, respectively. Clearance was increased by 24% for patients receiving oxygen support. The inter-individual variabilities in clearance and apparent volume of distribution were 15.6% and 80.4%, respectively, and the residual variability was 34.2% as a coefficient of variation. CONCLUSION: Application of the findings in this study to patient care may permit selection of an appropriate initial maintenance dosage to achieve target theophylline concentrations, thus enabling the clinician to achieve the desired therapeutic effect in very premature Japanese infants.
机译:目的:使用非线性混合效应模型评估早产儿茶碱的总体药代动力学。方法:收集了从107例日本早产儿的常规茶碱监测中获得的167份血清浓度测量值。结果:最终药代动力学参数为CL(mL / h)= [6.98。体重(BW)(kg)(2.17)+ 0.244。孕后年龄(周)]。 1.24(氧气载体),Vd(L)= 0.492。体重(kg)和F = 0.660。接受氧气支持的患者的清除率增加了24%。清除率和表观分布量的个体间差异分别为15.6%和80.4%,而作为变异系数的剩余变异性为34.2%。结论:本研究结果在患者护理中的应用可能允许选择适当的初始维持剂量以达到靶茶碱浓度,从而使临床医生能够在非常早的日本婴儿中获得所需的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号